Catalyst

Slingshot members are tracking this event:

Viking (VKTX) Releases Preliminary Results from Proof-of-Concept (POC) Study Assessing VK2809 in Glycogen Storage Disease Ia

Source Link:
http://www.prnewswire.com/news-releases/viking-therapeutics-announces-initial-results-from-in-vivo-proof-of-concept-study-of-vk2809-in-glycogen-storage-disease-ia-gsd-ia-300404769.html

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
VKTX
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Feb 09, 2017
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Preliminary Results, Proof-of-concept, Poc, Vk2809, Glycogen Storage Disease Ia
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.